Related references
Note: Only part of the references are listed.Reduced perlecan expression and accumulation in human carotid atherosclerotic lesions
Phan-Kiet Tran et al.
ATHEROSCLEROSIS (2007)
Divergent effects of matrix metalloproteinase-3, metalloproteinase-7, metalloproteinase-9, and metalloproteinase-12 on atherosclerotic plaque stability in mouse brachiocephalic arteries
JL Johnson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Heparan sulfate: A complex polymer charged with biological activity
JM Whitelock et al.
CHEMICAL REVIEWS (2005)
Development of experimental designs for atherosclerosis studies in mice
A Daugherty et al.
METHODS (2005)
Distinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: Evidence for a protective role for glucosamine in atherosclerosis
Wenlan Duan et al.
CARDIOVASCULAR DIABETOLOGY (2005)
Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan
PK Tran et al.
CIRCULATION RESEARCH (2004)
Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100
C Flood et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteries
MG Kinsella et al.
ATHEROSCLEROSIS (2004)
Atherosclerosis in perlecan heterozygous mice
RK Vikramadithyan et al.
JOURNAL OF LIPID RESEARCH (2004)
Proteoglycans in atherosclerosis and restenosis - Key roles for versican
TN Wight et al.
CIRCULATION RESEARCH (2004)
Apoptotic cell death in atherosclerosis
TD Littlewood et al.
CURRENT OPINION IN LIPIDOLOGY (2003)
Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney
M Rossi et al.
EMBO JOURNAL (2003)
Identification of the proteoglycan binding site in apolipoprotein B48
C Flood et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
K Skålén et al.
NATURE (2002)
Endogenous heparin activity deficiency: the 'Missing Link' in atherogenesis?
H Engelberg
ATHEROSCLEROSIS (2001)
Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (Perlecan) and atherogenicity
S Pillarisetti
TRENDS IN CARDIOVASCULAR MEDICINE (2000)
Share Paper
